Takuya Tatebe
Overview
Explore the profile of Takuya Tatebe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kikuchi K, Tatebe T, Sudo Y, Yokoyama M, Kidana K, Chiu Y, et al.
J Neurosci
. 2021 Jun;
41(28):6173-6185.
PMID: 34099509
Alzheimer's disease (AD) is characterized by the extensive deposition of amyloid-β peptide (Aβ) in the brain. Brain Aβ level is regulated by a balance between Aβ production and clearance. The...
2.
Kidana K, Tatebe T, Ito K, Hara N, Kakita A, Saito T, et al.
EMBO Mol Med
. 2018 Jan;
10(3).
PMID: 29311134
Deposition of amyloid-β (Aβ) as senile plaques is one of the pathological hallmarks in the brains of Alzheimer's disease (AD) patients. In addition, glial activation has been found in AD...
3.
Kikuchi K, Kidana K, Tatebe T, Tomita T
J Cell Biochem
. 2017 May;
118(12):4183-4190.
PMID: 28488760
Amyloid-β protein (Aβ) is the main component of senile plaques in the brains of Alzheimer disease (AD) patients. Aβ is proteolytically derived from amyloid-β precursor protein by β- and γ-secretases....
4.
Ito K, Tatebe T, Suzuki K, Hirayama T, Hayakawa M, Kubo H, et al.
Eur J Pharmacol
. 2017 Feb;
798:16-25.
PMID: 28167259
Memantine, an uncompetitive glutamatergic N-methyl-D-aspartate (NMDA) receptor antagonist, is widely used as medication for the treatment of Alzheimer's disease (AD). It has been reported that memantine reduces amyloid-β peptide (Aβ)...